Close

Analyst Ratings for Clearside Biomedical (CLSD) [Sells]

CLSD Rating Summary

CLSD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CLSD
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $5.00 (+296.8%) * Over Last 12-Mos
Rating Score: 7.3 / 10   Percentile Rank: 78%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/5/2018 JPMorgan N/A Downgrade Underweight
(Overweight)
8.00
(16.00)
5.56
(1.26)
-77.34% Details